Professor Simon Brown BMedSci, MBBS, DA(UK), FACEM, PhD
Professor Simon Brown graduated in Medicine from the University of Tasmania in 1988 and then worked in a variety of clinical posts in New Zealand, Western Australia, England and Queensland and completed specialty training in Emergency Medicine (FACEM) in 1996. He returned to Tasmania to work as a Staff Specialist at the Royal Hobart Hospital in Tasmania from 1997-2003 where he was Director of Emergency Medicine from 1999. During this time he also completed a PhD in Clinical Immunology as an extramural student of Flinders University. He moved to Western Australia in 2003 and was appointed to an academic post with the University of Western Australia in 2004, initially based at Fremantle Hospital and then transferred to Royal Perth Hospital to establish the Centre for Clinical Research in Emergency Medicine in 2008. He works clinically as a Consultant in Emergency Medicine, Royal Perth Hospital and is also a visiting Consultant to the Royal Hobart Hospital in Tasmania where he manages the Tasmanian Jack Jumper Venom Allergy Program [PDF, 1.8MB]. He is an examiner for the Australasian College for Emergency Medicine and assists with the postgraduate clinical training program in Emergency Medicine at Royal Perth Hospital. Professor Brown is also a Member of the Australasian Society of Clinical Immunology and Allergy.
Professor Brown's main research interests are the pathophysiology and management of critical illnesses including life-threatening allergy (anaphylaxis) and severe sepsis, immunotherapy for preventing anaphylaxis, and the clinical use of antivenoms for snake and spider envenoming. Research interests are:
- Clinical immunology/allergy
- Insect venom allergy and immunotherapy.
- Antivenoms - clinical use
Brown SGA, Wiese MD, Blackman KE, Heddle RJ. 2003. Ant venom immunotherapy: a double blind placebo controlled crossover trial. Lancet 361:1001-6. [NCBI PubMed Entry]
Brown SGA, Franks RW, Baldo BA, Heddle RJ. 2003. Prevalence, severity, and natural history of jack jumper ant venom allergy in Tasmania. The Journal of Allergy and Clinical Immunology 111:187-92. [NCBI PubMed Entry]
Brown SGA. 2004. Clinical features and severity grading of anaphylaxis. The Journal of Allergy and Clinical Immunology 114:371-6. [NCBI PubMed Entry]
Brown SGA, Blackman KE, Stenlake V, Heddle RJ. 2004. Insect sting anaphylaxis; prospective evaluation of treatment with intravenous adrenaline and volume resuscitation. Emergency Medicine Journal 21: 149-54. [NCBI PubMed Entry]
Wiese MD, Brown SGA, Chataway TK, Davies NW, Milne RW, Aulfrey SJ, Heddle RJ. 2007. Myrmecia pilosula (Jack Jumper) Ant Venom: Identification of Allergens and Revised Nomenclature. Allergy 62:437-443. [NCBI PubMed Entry]
Isbister GK, O'Leary MA, Schneider JJ, Brown SGA, Currie BJ on behalf of the ASP Investigators. 2007. Efficacy of antivenom against the procoagulant effect of Australian brown snake (Pseudonaja sp.) venom: In vivo and in vitro studies. Toxicon 49:57-67. [NCBI PubMed Entry]
Isbister GK, Brown SGA, MacDonald E, White J, Currie BJ for the ASP Investigators. 2008. Current use of Australian snake antivenoms and frequency of immediate-type hypersensitivity reactions and anaphylaxis. Medical Journal of Australia 188:473-6. [NCBI PubMed Entry]
Isbister GK, Brown SGA, Miller M, Tankel A, MacDonald E, Stokes B, Ellis R, Nagree Y, Wilkes GJ, James R, Short A, Holdgate A. 2008. A randomised controlled trial of intramuscular versus intravenous antivenom for latrodectism - the RAVE study. Quarterly Journal of Medicine 101:557-65. [NCBI PubMed Entry]
Isbister GK, Duffull SB, Brown SGA, for the ASP Investigators. 2009. Failure of antivenom to improve recovery in Australian snakebite coagulopathy. Quarterly Journal of Medicine 102:563-8. [NCBI PubMed Entry]
Brown SGA, Caruso N, Borland ML, McCoubrie DL, Celenza A, Isbister GK, on behalf of the ASP investigators. 2009. Clotting factor replacement and recovery from snake venom induced consumption coagulopathy. Intensive Care Medicine. [NCBI PubMed Entry]